|
1
|
Vitaliani R, Mason W, Ances B, Zwerdling
T, Jiang Z and Dalmau J: Paraneoplastic encephalitis, psychiatric
symptoms, and hypoventilation in ovarian teratoma. Ann Neurol.
58:594–604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prüss H, Dalmau J, Harms L, Höltje M,
Ahnert-Hilger G, Borowski K, Stoecker W and Wandinger KP:
Retrospective analysis of NMDA receptor antibodies in encephalitis
of unknown origin. Neurology. 75:1735–1739. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barry H, Byrne S, Barrett E, Murphy KC and
Cotter DR: Anti-N-methyl-d-aspartate receptor encephalitis: Review
of clinical presentation, diagnosis and treatment. BJPsych Bull.
39:19–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gwathmey K, Balogun RA and Burns T:
Neurologic indications for therapeutic plasma exchange: 2013
update. J Clin Apher. 29:211–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmitt SE, Pargeon K, Frechette ES,
Hirsch LJ, Dalmau J and Friedman D: Extreme delta brush: A unique
EEG pattern in adults with anti-NMDA receptor encephalitis.
Neurology. 79:1094–1100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuliani L, Graus F, Giometto B, Bien C and
Vincent A: Central nervous system neuronal surface antibody
associated syndromes: Review and guidelines for recognition. J
Neurol Neurosurg Psychiatry. 83:638–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Granerod J, Ambrose HE, Davies NW, Clewley
JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ,
Solomon T, et al: UK Health Protection Agency (HPA) Aetiology of
Encephalitis Study Group: Causes of encephalitis and differences in
their clinical presentations in England: A multicentre,
population-based prospective study. Lancet Infect Dis. 10:835–844.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Titulaer MJ, McCracken L, Gabilondo I,
Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I,
Martinez-Hernandez E, et al: Treatment and prognostic factors for
long-term outcome in patients with anti-NMDA receptor encephalitis:
An observational cohort study. Lancet Neurol. 12:157–165. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Irani SR, Bera K, Waters P, Zuliani L,
Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, et
al: N-methyl-D-aspartate antibody encephalitis: Temporal
progression of clinical and paraclinical observations in a
predominantly non-paraneoplastic disorder of both sexes. Brain.
133:1655–1667. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dalmau J, Gleichman AJ, Hughes EG, Rossi
JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R and
Lynch DR: Anti-NMDA-receptor encephalitis: Case series and analysis
of the effects of antibodies. Lancet Neurol. 7:1091–1098. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Motta E, Gołba A, Kazibutowska Z, Huć M
and Stęposz A: Anti-NMDA receptor encephalitis-case report. Neurol
Neurochir Pol. 46:288–293. 2012.(In Polish). PubMed/NCBI
|
|
12
|
Hammer C, Stepniak B, Schneider A, Papiol
S, Tantra M, Begemann M, Sirén AL, Pardo LA, Sperling S, Jofrry S
Mohd, et al: Neuropsychiatric disease relevance of circulating
anti-NMDA receptor autoantibodies depends on blood-brain barrier
integrity. Mol Psychiatry. 19:1143–1149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iizuka T, Sakai F, Ide T, Monzen T, Yoshii
S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, et al: Anti-NMDA
receptor encephalitis in Japan: Long-term outcome without tumor
removal. Neurology. 70:504–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peery HE, Day GS, Doja A, Xia C, Fritzler
MJ and Foster WG: Anti-NMDA receptor encephalitis in children: The
disorder, its diagnosis, and treatment. Handb Clin Neurol.
112:1229–1233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mann AP, Grebenciucova E and Lukas RV:
Anti-N-methyl-D-aspartate-receptor encephalitis: Diagnosis, optimal
management, and challenges. Ther Clin Risk Manag. 10:517–525. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Florance NR, Davis RL, Lam C, Szperka C,
Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, et al:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children
and adolescents. Ann Neurol. 66:11–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dalmau J, Lancaster E, Martinez-Hernandez
E, Rosenfeld MR and Balice-Gordon R: Clinical experience and
laboratory investigations in patients with anti-NMDAR encephalitis.
Lancet Neurol. 10:63–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Gao D, Ye H and Su Y: [Safety of
plasma exchange therapy in patients with anti-NMDA receptor
encephalitis. Zhonghua Yi Xue Za Zhi. 95:1505–1508. 2015.(In
Chinese). PubMed/NCBI
|
|
19
|
Shahani L: Steroid unresponsive anti-NMDA
receptor encephalitis during pregnancy successfully treated with
plasmapheresis. BMJ Case Rep 2015 (apr29 1). 292015.
|
|
20
|
DeSena AD, Noland DK, Matevosyan K, King
K, Phillips L, Qureshi SS, Greenberg BM and Graves D: Intravenous
methylprednisolone versus therapeutic plasma exchange for treatment
of anti-N-methyl-D-aspartate receptor antibody encephalitis: A
retrospective review. J Clin Apher. 30:212–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nunez-Enamorado N, Camacho-Salas A,
Belda-Hofheinz S, Cordero-Castro C, Simon-De Las Heras R, Saiz-Diaz
R, Martinez-Sarries FJ, Martinez-Menendez B and Graus F: Fast and
spectacular clinical response to plasmapheresis in a paediatric
case of anti-NMDA encephalitis. Rev Neurol. 54:420–424. 2012.(In
Spanish). PubMed/NCBI
|
|
22
|
Mirza MK, Pogoriler J, Paral K,
Ananthanarayanan V, Mandal S, Mazin A, Baron B and Richa E: Adjunct
therapeutic plasma exchange for anti-N-methyl-D-aspartate receptor
antibody encephalitis: A case report and review of literature. J
Clin Apher. 26:362–365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ikeguchi R, Shibuya K, Akiyama S, Hino S,
Kubo H, Takeda T, Shibata N and Yamamoto K: Rituximab used
successfully in the treatment of anti-NMDA receptor encephalitis.
Intern Med. 51:1585–1589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schwartz J, Winters JL, Padmanabhan A,
Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams
ME, Wu Y and Shaz BH: Guidelines on the use of therapeutic
apheresis in clinical practice-evidence-based approach from the
Writing Committee of the American Society for Apheresis: The sixth
special issue. J Clin Apher. 28:145–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ehrlich S, Fassbender CM, Blaes C, Finke
C, Günther A, Harms L, Hoffmann F, Jahner K, Klingel R, Kraft A, et
al: Therapeutic apheresis for autoimmune encephalitis: A nationwide
data collection. Nervenarzt. 84:498–507. 2013.(In German).
View Article : Google Scholar : PubMed/NCBI
|
